Consumer & Retail

According to a market report by Lucintel, the future of the gastrointestinal drug market looks promising with opportunities in the cure of gastro-esophageal reflux disease, inflammatory bowel disease, and irritable bowel syndrome disorders/applications. The global gastrointestinal drug market is expected to grow with a CAGR of 4%-6% from 2022 to 2027. The major drivers for this market are increasing number of gastrointestinal disorder/diseases among the elderlypeople, increasing expenditure in the expansion of healthcare infrastructure coupled with government investment life science and the healthcare sector, and trials conducted by various pharmaceutical companies for introduction of new products.

In this market, acid neutralizers, anti-diarrheal and laxatives, antiemetic and anti-nauseants, anti-inflammatory drugs, biologics, and antispasmodic are used as gastrointestinal drugs. Lucintel forecasts that acid neutralizers will remain the largest segment and witness highest growth due to increasing consumption of antacid by growing geriatric population that are suffering from Gastroesophageal Reflux Disease (GERD), higher incidences of acidity due to unhealthy lifestyle, and side effects of non-steroidal drugs and anti-inflammatory drugs.

North America is expected to remain the largest market due to large number of geriatric population, lifestyles and eating habits (fast food eating), and increasing lifestyle diseases in North America region.

Takeda Pharmaceticals, Allergan Plc, Novo Nordisk A/S, AstraZeneca Plc, and Johnson & Johnson are among the major suppliers of gastrointestinal drugs.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global gastrointestinal drug market by drug class, route of administration, application, distribution channel, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Gastrointestinal Drug Market 2022-2027: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy as it provides a comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global gastrointestinal drug market by drug class, route of administration, application, distribution channel, and region as follows:


































This 180-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/gastrointestinal-drug-market.aspx or write us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

This report answers following 11 key questions:

Q.1 What are some of the most promising potential, high growth opportunities for the global gastrointestinal drug market by drug class (acid neutralizers, antidiarrheal and laxatives, antiemetic and antinauseants, anti-inflammatory drugs, biologics, others (antispasmodic etc.)), route of administration (oral, intravenous, rectal), application (gastro-esophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)? 

Q.2 Which segments will grow at a faster pace and why?

Q.3 Which regions will grow at a faster pace and why?

Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?

Q.5 What are the business risks and threats to the market?

Q.6 What are the emerging trends in this market and the reasons behind them?

Q.7 What are the changing demands of customers in the market?

Q.8 What are the new developments in the market? Which companies are leading these developments?

Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?

Q.10 What are some of the competitive products and processes in this area and how big of a threat do they pose for loss of market share via material or product substitution?

Q.11 What M & A activities have taken place in the last 5 years in this market?